Authors
Latest:
Annual Stroke Costs to Health Plans Among Atrial Fibrillation PatientsAn incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
Latest:
A Closer Look at New FDA Actions Merck's DuleraDulera (mometasone furoate and formoterol dehydrate) Inhalation Aerosol is FDA-approved for the treatment of asthma in patients aged 12 and older.
Latest:
The Importance of MentoringPharmacy students need to understand the value of mentoring and seek a quality mentor while still in school. Here are some guidelines for establishing this vital support system.
Latest:
Telepharmacy and Its Impact on Formulary AdherenceTelepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Pharmacy's Societal Mission and the Need for a ForumMr. McAllister is a health-systems consultant based in Chapel Hill, NC.
Latest:
Therapeutic Interchange of Carvedilol to Bisoprolol for Chronic Heart Failure: The Singapore ExperienceA carvedilol to bisoprolol interchange program was carried out in a Singapore hospital with substantial cost savings of US$116 per patient-year without increase in adverse outcomes.
Latest:
Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast CancerCompared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.
Latest:
The Expanding Health Benefits of Prebiotics and ProbioticsA Continuing Education program, featured in the February 2018 issue of Pharmacy Times.
Latest:
Emergent Management of Ischemic Stroke: Treatment ABCsStroke affects nearly 700,000 Americans a year. Emergency management is key to a positive patient outcome.
Latest:
Total Health Care in Aisle 5Pharmacy jobs at grocery chains offer pharmacists regular contact with their patients, a positive work environment, and a total health care approach to their pharmacy practice.
Latest:
Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease TherapiesExamination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.
Latest:
Pharmacists Play Role in Impairment Care PlanningCollaborating with providers offers opportunities to help patients maintain their brain health.
Latest:
Where's the Special in Specialty? Has the Increase in the Number of Players Diluted Services?The growing cost of specialty products places greater importance on the support that patients receive.
Latest:
2010 Lifetime Achievement: Randy McDonoughRandy McDonough has bettered the field through his tireless work on behalf of patients, with a special focus on medication therapy management.
Latest:
Pharmacosynchrony: Road Map to Transformation in Pharmacy Benefit ManagementPharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.
Latest:
The Real Scoop on Data WarehousesThe implementation of a data warehouse, a relational database for query and analysis, can help a specialty pharmacy utilize its data to the fullest.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Mitigating Drug Diversion Risk: More Than Just Narcotics, Specialty Needs to Look at This Growing ProblemExpensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.
Latest:
Economic Impact of Fidaxomicin on CDI Treatment in United StatesFidaxomicin has shown promise as an effective treatment option for Clostridium difficile infections, but no pharmacoeconomic studies have been performed to date.
